Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2024-02-13 00:00:00 ET · period of report 2021-12-28 · accession 0000950170-24-014523 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-02-13 | 2021-12-28 | BBIO | Valantine Hannah | Dir | P - Purchase | $12.96 | +3,433 | 3,433 | New | +$44.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-28 | P | A | 1,891 | $13.18 | 1,891 | I By Spouse | — | — | |
| 2 | Common | Common Stock | 2021-12-28 | P | A | 1,542 | $12.68 | 3,433 | I By Spouse | — | — |